(Q43135271)

14 November 2017

title

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer (English)

1 reference

14 November 2017

1 reference

9

Kiyohiko Hatake

1 reference

14 November 2017

Satoshi Matsusaka

1

1 reference

14 November 2017

Keisho Chìn

2

1 reference

14 November 2017

Mariko Ogura

3

1 reference

14 November 2017

Mitsukuni Suenaga

4

1 reference

14 November 2017

Eiji Shinozaki

5

1 reference

14 November 2017

Yuji Mishima

6

1 reference

14 November 2017

Yasuhito Terui

7

1 reference

14 November 2017

Nobuyuki Mizunuma

8

1 reference

14 November 2017

publication date

12 January 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

101

1 reference

14 November 2017

issue

4

1 reference

14 November 2017

page(s)

1067-1071

1 reference

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Circulating tumour cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

The measurement and therapeutic implications of circulating tumour cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01492.X

10.1111/J.1349-7006.2010.01492.X

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference